Videos

Metastatic Kidney Cancer Requires a Multidisciplinary Approach to Care

March 31st 2025, 9:00pm

Video

CURE spoke with Dr. William C. Huang about what kind of team may be required to treat a patient with metastatic kidney cancer.

Research Shines Light on Disparities Across Breast Cancer Care

March 29th 2025, 2:00pm

Video

Dr. Regina Hampton discusses key factors contributing to this disparity, and how healthcare systems can address these challenges.

Why Physical Therapy Should Begin at the Time of a Cancer Diagnosis

March 28th 2025, 7:11pm

Video

CURE spoke with Leslie Waltke about the importance of physical therapy during a cancer journey.

Clinical Trial to Evaluate Opdivo, Opdualag in Glioblastoma

March 27th 2025, 8:53pm

Video

The phase 2 GIANT trial will evaluate Opdivo with or without relatlimab in IDH-wildtype newly diagnosed glioblastoma.

Rina-S Generates Antitumor Activity in Heavily Pretreated Ovarian Cancer

March 27th 2025, 1:00pm

Video

Treatment with Rina-S showed antitumor activity in heavily pretreated patients with advanced ovarian cancer, according to the phase 2 RAINFOL-01 study.

A Patient Advocate Highlights Kidney Cancer Awareness and Specialized Care

March 26th 2025, 8:00pm

Video

Sid Sadler discusses kidney cancer awareness, patient advocacy and the need for specialized care to improve access to treatments and clinical trials.

Top 3 Takeaways From ASCO GU 2025

March 25th 2025, 8:16pm

Video

Dr. Emre Yekedüz discusses his top 3 key takeaways from attending the 2025 ASCO Genitourinary (GU) Cancers Symposium.

Navigating RRMM: Helpful Resources and Advice for Patients Facing Disease Progression

March 24th 2025, 8:59pm

Video

Panelists discuss how multiple myeloma support resources range from formal organizations like the International Myeloma Foundation and Multiple Myeloma Research Foundation to online patient communities, hospital-based support groups, and specialized social media networks, with advice for newly relapsed patients emphasizing the importance of allowing emotional processing before taking action, seeking second opinions from myeloma specialists, asking detailed questions about all available options including clinical trials, connecting with patients who’ve undergone similar treatments, maintaining hope amid setbacks, and recognizing that relapses, while challenging, often open doors to novel therapeutic approaches that can effectively control the disease for extended periods.

Guidance for Caregivers: Supporting a Loved One Through Late-Line RRMM

March 24th 2025, 8:56pm

Video

Panelists discuss how caregivers supporting loved ones with late-line relapsed/refractory multiple myeloma (RRMM) should prioritize both patient and self-care by establishing sustainable support systems, maintaining open communication with the health care team, educating themselves about treatment options while acknowledging emotional boundaries, creating practical organizational systems for medication management and appointment tracking, seeking respite care when needed, connecting with caregiver support groups for shared experiences, participating in decision-making without overshadowing the patient’s voice, preparing contingency plans for complications, and finding moments of normalcy and joy amid the challenges of advanced disease management.

Effective Communication Strategies: Sharing Concerns With Your Medical Team in Late-Line RRMM

March 24th 2025, 8:54pm

Video

Panelists discuss how effective communication with medical teams in advanced multiple myeloma requires proactive strategies including preparing prioritized question lists before appointments, bringing a designated note-taking advocate to consultations, utilizing patient portals for nonurgent concerns, clearly articulating quality of life impacts rather than just symptom presence, requesting dedicated time for treatment planning discussions, recording conversations (with permission) for later review, maintaining symptom diaries with specific details, and establishing relationships with nurse navigators who can facilitate more timely responses—approaches that collectively ensure patient needs are comprehensively addressed despite the complex nature of late-line treatment decisions.